Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2023-2030
As per Triton Market Research’s report, the cough syrup market in Latin America is projected to register growth at a CAGR of 3.18% during the forecasted period from 2023 to 2030.
Report scope can be customized per your requirements - Request Free Sample ReportÂ
The
countries assessed in the region are:
•       Â
Brazil
•       Â
Mexico
•       Â
Rest of Latin America
In Latin America, the cough
syrup market is fueled by multiple factors, including rising concern for
respiratory well-being. Concurrently, the region’s rising middle class and
growing health consciousness contribute to a growing preference for
over-the-counter remedies. However, expansion in this market encounters
obstacles arising from regulatory challenges, disparities in healthcare
infrastructure, and the proliferation of counterfeit medications.
Brazil
captures the highest share of the region’s market. The
nation stands to host Latin America’s largest pharmaceutical sector. The transition
in Brazil’s administration during 2022 brought about notable changes in the
pharmaceutical landscape. Specifically, it reduced the audit requirements for
certain pharmaceutical products and simplified the process of introducing new
products. With fewer regulatory hurdles and a smoother product launch process,
global players became more inclined to tap into the Brazilian pharmaceutical
market. As a result, this transformation has augmented the cough syrup market’s
expansion.
Cough suppressants,
also known as antitussives, are medications that mitigate or eliminate coughing
by targeting the brain’s cough reflex to reduce the urge to cough. Their demand
has risen due to various factors, including ongoing global health challenges
such as COVID-19. Coughing is a common symptom of respiratory infections, which
has heightened public awareness regarding coughing and its potential for
transmitting diseases. Consequently, individuals experiencing mild coughs due
to allergies, colds, or other causes may be more inclined to seek cough
suppressants to manage their symptoms and reduce the perceived risk of
spreading illness.
The
market’s growth is determined based on product type, age group, and
distribution channel. Based on product type, it is
sectioned into cough suppressants, combination medicines, and expectorants.
Some of the known companies in the
market are GSK Plc, Reckitt Benckiser Group Plc, Pfizer Inc, Novartis AG, The
Procter & Gamble Company, and Sanofi SA.
GSK Plc, a
multinational conglomerate in the pharmaceutical and healthcare sector, has
solidified its position as a leader through scientific innovation, research,
and collaborative efforts. Offering a comprehensive range of medications,
vaccines, and consumer healthcare products, GSK addresses a diverse spectrum of
health concerns across its three primary business segments: pharmaceuticals,
vaccines, and consumer healthcare. With a global footprint encompassing Latin
America and other regions, GSK’s headquarters is situated in Brentford, UK.
Key deliverables of the report:
·      Market CAGR during the forecasting
years 2023-2030
·      Detailed data highlighting key
insights, industry components, and market strategies
·      Comprehensive information and
estimation of the cough syrup market revenue growth in Latin America and its
influence on the parent market
·      In-depth study of forthcoming trends
in consumer behavioral patterns
·      A meticulous analysis of the
competitive landscape, vendor scorecard, and Porter’s Five Forces
·      A wide-ranging study of factors that
will challenge the LA cough syrup market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.Â
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. LATIN
AMERICA COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE COUGH SYRUP MARKET
2.1.1. COVID-19
IMPACT
2.1.2. UKRAINE-RUSSIA
WAR IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. INDUSTRY
COMPONENTS
2.3.1. RAW
MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. RETAILERS
2.4. REGULATORY
FRAMEWORK
2.5. KEY
MARKET STRATEGIES
2.5.1. COLLABORATIONS
2.5.2. PRODUCT
LAUNCHES
2.5.3. ACQUISITIONS
2.5.4. BUSINESS
DIVESTITURES & EXPANSIONS
2.6. MARKET
DRIVERS
2.6.1. HIGH INCIDENCE OF
RESPIRATORY AILMENTS
2.6.2. VULNERABILITY
TO RESPIRATORY DISEASES AMONG THE GERIATRIC POPULATION
2.6.3. INNOVATIONS
IN COUGH SYRUPS
2.7. MARKET
CHALLENGES
2.7.1. OVERDOSE
RISKS ASSOCIATED WITH COUGH SYRUPS
2.7.2. STRICT
REGULATORY REQUIREMENTS
2.7.3. INCREASING
COUGH SYRUP DEATHS DUE TO TOXIC INGREDIENTS
2.8. MARKET
OPPORTUNITIES
2.8.1. SELF-MEDICATION TRENDS
INCREASE DEMAND FOR OTC DRUGS
2.8.2. HERBAL
COUGH SYRUPS EMERGE AS A SAFER ALTERNATIVE
2.8.3. EASE
OF PURCHASE OFFERED BY E-COMMERCE CHANNELS
2.8.4. AVAILABILITY
OF SUGAR-FREE COUGH SYRUPS
2.8.5. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9. ANALYST
PERSPECTIVE
3. LATIN
AMERICA COUGH SYRUP MARKET – BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS
3.2. COMBINATION
MEDICINES
3.3. EXPECTORANTS
4. LATIN
AMERICA COUGH SYRUP MARKET – BY AGE GROUP
4.1. ADULTS
4.2. ADOLESCENTS
4.3. PEDIATRIC
5. LATIN
AMERICA COUGH SYRUP MARKET – BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACIES
5.2. HOSPITAL
PHARMACIES
5.3. E-PHARMACIES
6. LATIN
AMERICA COUGH SYRUP MARKET – BY COUNTRY OUTLOOK
6.1. BRAZIL
6.1.1. BRAZIL
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.2. MEXICO
6.2.1. MEXICO
COUGH SYRUP MARKET FORECAST & PROSPECTS
6.3. REST
OF LATIN AMERICA
6.3.1. REST
OF LATIN AMERICA COUGH SYRUP MARKET FORECAST & PROSPECTS
7. COMPETITIVE
LANDSCAPE
7.1. GSK
PLC
7.1.1. OVERVIEW
7.1.2. PRODUCT
PORTFOLIO
7.1.3. KEY
STRENGTHS
7.1.4. KEY
CHALLENGES
7.2. PFIZER
INC
7.2.1. OVERVIEW
7.2.2. PRODUCT
PORTFOLIO
7.2.3. KEY
STRENGTHS
7.2.4. KEY
CHALLENGES
7.3. NOVARTIS
AG
7.3.1. OVERVIEW
7.3.2. PRODUCT
PORTFOLIO
7.3.3. KEY
STRENGTHS
7.3.4. KEY
CHALLENGES
7.4. RECKITT
BENCKISER GROUP PLC
7.4.1. OVERVIEW
7.4.2. PRODUCT
PORTFOLIO
7.4.3. KEY
STRENGTHS
7.4.4. KEY
CHALLENGES
7.5. THE PROCTER
& GAMBLE COMPANY
7.5.1. OVERVIEW
7.5.2. PRODUCT
PORTFOLIO
7.5.3. KEY
STRENGTHS
7.5.4. KEY
CHALLENGES
7.6. SANOFI
SA
7.6.1. OVERVIEW
7.6.2. PRODUCT
PORTFOLIO
7.6.3. KEY
STRENGTHS
7.6.4. KEY
CHALLENGES
7.7. CIPLA LIMITED
7.7.1. OVERVIEW
7.7.2. PRODUCT
PORTFOLIO
7.7.3. KEY
STRENGTHS
7.7.4. KEY
CHALLENGES
7.8. KENVUE
INC
7.8.1. OVERVIEW
7.8.2. PRODUCT
PORTFOLIO
7.8.3. KEY
STRENGTHS
7.8.4. KEY
CHALLENGES
7.9. ASTRAZENECA
PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT
PORTFOLIO
7.9.3. KEY
STRENGTHS
7.9.4. KEY
CHALLENGES
7.10. ACELLA
PHARMACEUTICALS LLC
7.10.1. OVERVIEW
7.10.2. PRODUCT
PORTFOLIO
7.10.3. KEY
STRENGTHS
7.10.4. KEY
CHALLENGES
7.11. THE
HIMALAYA WELLNESS COMPANY
7.11.1. OVERVIEW
7.11.2. PRODUCT
PORTFOLIO
7.11.3. KEY
STRENGTHS
7.11.4. KEY
CHALLENGES
7.12. MERCK
KGAA
7.12.1. OVERVIEW
7.12.2. PRODUCT
PORTFOLIO
7.12.3. KEY
STRENGTHS
7.12.4. KEY
CHALLENGES
7.13. ABBOTT
LABORATORIES
7.13.1. OVERVIEW
7.13.2. PRODUCT
PORTFOLIO
7.13.3. KEY
STRENGTHS
7.13.4. KEY
CHALLENGES
7.14. GLENMARK
PHARMACEUTICALS LIMITED
7.14.1. OVERVIEW
7.14.2. PRODUCT
PORTFOLIO
7.14.3. KEY
STRENGTHS
7.14.4. KEY
CHALLENGES
7.15. DABUR
INDIA LTD
7.15.1. OVERVIEW
7.15.2. PRODUCT
PORTFOLIO
7.15.3. KEY
STRENGTHS
7.15.4. KEY
CHALLENGES
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: LATIN AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2023-2030 (IN $ MILLION)
TABLE 9: LATIN AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2023-2030 (IN $ MILLION)
TABLE 10: LATIN
AMERICA COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: INDUSTRY COMPONENTS
FIGURE 2: LATIN AMERICA COUGH
SYRUP MARKET, BY PRODUCT TYPE, 2022 & 2030 (IN %)
FIGURE 3: LATIN AMERICA COUGH
SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2030 (IN $ MILLION)
FIGURE 4: LATIN AMERICA COUGH
SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2030 (IN $ MILLION)
FIGURE 5: LATIN AMERICA COUGH
SYRUP MARKET, BY AGE GROUP, 2022 & 2030 (IN %)
FIGURE 6: LATIN AMERICA COUGH
SYRUP MARKET, BY ADULTS, 2023-2030 (IN $ MILLION)
FIGURE 7: LATIN AMERICA COUGH
SYRUP MARKET, BY ADOLESCENTS, 2023-2030 (IN $ MILLION)
FIGURE 8: LATIN AMERICA COUGH
SYRUP MARKET, BY PEDIATRIC, 2023-2030 (IN $ MILLION)
FIGURE 9: LATIN AMERICA COUGH
SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022 & 2030 (IN %)
FIGURE 10: LATIN AMERICA COUGH
SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 11: LATIN AMERICA COUGH
SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 12: LATIN AMERICA COUGH
SYRUP MARKET, BY E-PHARMACIES, 2023-2030 (IN $ MILLION)
FIGURE 13: LATIN AMERICA COUGH
SYRUP MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 14: BRAZIL COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 15: MEXICO COUGH SYRUP
MARKET 2023-2030 (IN $ MILLION)
FIGURE 16: REST OF LATIN
AMERICA COUGH SYRUP MARKET 2023-2030 (IN $ MILLION)